Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 327 followers
Latest posts
Last updated about 1 hour ago
Human medicines European public assessment report (EPAR): Talmanco (previously Tadalafil Generics), tadalafil, Date of authorisation: 09/01/2017, Revision: 11, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Talmanco (previously Tadalafil Generics), tadalafil...
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 11, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan)...
Human medicines European public assessment report (EPAR): Ritonavir Viatris (previously Ritonavir Mylan), ritonavir, Date of authorisation: 09/11/2017, Revision: 20, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Ritonavir Viatris (previously Ritonavir Mylan)...
Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Date of authorisation: 18/07/2025, Revision: 3, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Date of authorisation...
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 May 2026
about 2 hours ago
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 May 2026
Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 24, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan)...
Good manufacturing practice: Multistakeholder workshop on expert contributions to artificial intelligence guidance development (Annex 22), Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 09:00 (CEST) to 1 July 2026, 18:00
about 2 hours ago
Good manufacturing practice: Multistakeholder workshop on expert contributions to artificial intelligence guidance...
Human medicines European public assessment report (EPAR): Pomalidomide Viatris, pomalidomide, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Pomalidomide Viatris, pomalidomide, Date of...
Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, emtricitabine,rilpivirine,tenofovir alafenamide, Date of authorisation: 19/08/2025, Revision: 2, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir...
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 20, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation...